Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Neuro-Oncology Advances|July 10, 2020
The soluble form of pan-RTK inhibitor and tumor suppressor LRIG1 mediates downregulation of AXL through direct protein-protein interaction in glioblastomaVirginie Neirinckx, Ann-Christin Hau, Anne Schuster, et al.
Ebiomedicine|June 7, 2024
HIV-related immune activation attenuates polyfunctional IgG and memory B-cell responses to Tdap immunization during pregnancyMartin Taton, Fabienne Willems, Cyprien Widomski, et al.
Nature|August 15, 2003
A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozymeMireille Dumoulin, Alexander M Last, Aline Desmyter, et al.
Biochimica Et Biophysica Acta|May 28, 2013
Structural determinants of specificity and catalytic mechanism in mammalian 25-kDa thiamine triphosphataseDavid Delvaux, Frédéric Kerff, Mamidanna R V S Murty, et al.
The Journal of Physical Chemistry. B|August 8, 2013
A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formationErwin De Genst, Pak-Ho Chan, Els Pardon, et al.
Biochemistry|September 26, 2008
Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrilsPak-Ho Chan, Els Pardon, Linda Menzer, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 11, 2023
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipientsDelphine Kemlin, Nicolas Gemander, Stéphanie Depickère, et al.
Journal of Structural Biology|May 17, 2016
The unexpected structure of the designed protein Octarellin V.1 forms a challenge for protein structure prediction toolsMaximiliano Figueroa, Mike Sleutel, Marylene Vandevenne, et al.
Kidney International Reports|March 14, 2024
Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant RecipientsNicolas Gemander, Delphine Kemlin, Stéphanie Depickère, et al.
Vaccine|November 28, 2024
COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipientsNicolas Gemander, Delphine Kemlin, Stéphanie Depickère, et al.
Pageof 8